Publications
Download CSV
Download XLSX
Download TXT
Tables
2026 (67)
2025 (848)
2024 (934)
2023 (918)
2022 (1034)
2021 (1042)
2020 (874)
2019 (789)
2018 (912)
2017 (936)
2016 (881)
2015 (693)
2014 (619)
2013 (473)
2012 (344)
2011 (199)
2010 (72)
2009 (38)
2008 (39)
2007 (13)
2006 (19)
2005 (9)
2004 (3)
2003 (2)
2002 (1)
All (11759)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
Br. J. Haematol.
JSON
ISSN
1365-2141
ISSN-L
0007-1048
IUID
f9fee8a3cff847318ce252fd68b8a2e0
Modified
2020-11-27T13:12:53.280Z
Created
2018-12-05T10:25:05.693Z
Year 2026
PubMed
DOI
Crossref
Comorbidities and mutations including single- and multihit TET2 mutations in relation to outcome in chronic myelomonocytic leukaemia-A population-based study.
Kynning MK, Westerberg E, Forsell L, ..., Ejerblad E,
Ungerstedt J
Br. J. Haematol.
208
(2) 514-523 [2026-02-00; online 2025-11-25]
Year 2022
PubMed
DOI
Crossref
Checkpoint CD47 expression in classical Hodgkin lymphoma.
Gholiha AR
,
Hollander P
, Löf L, ...,
Amini RM
, Enblad G
Br. J. Haematol.
197
(5) 580-589 [2022-06-00; online 2022-03-17]
PubMed
DOI
Crossref
International validation of the EORTC QLQ-CLL17 questionnaire for assessment of health-related quality of life for patients with chronic lymphocytic leukaemia.
Oerlemans S
, Efficace F, Kieffer JM, ..., van de Poll-Franse L, EORTC Quality of Life Group
Br. J. Haematol.
197
(4) 431-441 [2022-05-00; online 2022-03-07]
Year 2020
PubMed
DOI
Crossref
Prevalence, distribution and predictive value of XPO1 mutation in a real-life chronic lymphocytic leukaemia cohort.
Tueur G,
Lazarian G
, Eclache V, ..., Cymbalista F, Baran-Marszak F
Br. J. Haematol.
191
(3) e90-e94 [2020-11-00; online 2020-08-13]
Year 2019
PubMed
DOI
Crossref
Expression of GNAZ, encoding the Gαz protein, predicts survival in mantle cell lymphoma.
Mundt F, Merrien M, Nygren L, ...,
Sander B
,
Wasik AM
Br. J. Haematol.
185
(4) 708-712 [2019-05-00; online 2019-02-20]
PubMed
DOI
Crossref
NQO1*2 polymorphism predicts overall survival in MDS patients.
Moudra A
, Minarik L, Vancurova M, ...,
Hodny Z
,
Jonasova A
Br. J. Haematol.
184
(2) 305-308 [2019-01-00; online 2018-01-24]
Year 2015
PubMed
DOI
Crossref
Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts.
Conte S, Katayama S, Vesterlund L, ..., Kere J, Hellström-Lindberg E
Br. J. Haematol.
171
(4) 478-490 [2015-11-00; online 2015-08-10]
PubMed
DOI
Crossref
The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013.
Olsson L, Ivanov Öfverholm I, Norén-Nyström U, ..., Barbany G, Johansson B
Br. J. Haematol.
170
(6) 847-858 [2015-09-00; online 2015-05-27]
Year 2014
PubMed
DOI
Crossref
Impact of ABCB1 single nucleotide polymorphisms 1236C>T and 2677G>T on overall survival in FLT3 wild-type de novo AML patients with normal karyotype.
Jakobsen Falk I, Fyrberg A, Paul E, ..., Gréen H, Lotfi K
Br. J. Haematol.
167
(5) 671-680 [2014-12-00; online 2014-08-23]
PubMed
DOI
Crossref
Recurrent GATA1 mutations in Diamond-Blackfan anaemia.
Klar J, Khalfallah A, Arzoo PS, Gazda HT, Dahl N
Br. J. Haematol.
166
(6) 949-951 [2014-09-00; online 2014-04-28]
SciLifeLab Data Centre
Publications
9.5.1